Evidence map›Paper›PMID 26663853›Full record

ReviewWiley interdisciplinary reviews. Nanomedicine and nanobiotechnology2016

Intraoperative mapping of sentinel lymph node metastases using a clinically translated ultrasmall silica nanoparticle.

Michelle S Bradbury, Mohan Pauliah, Pat Zanzonico, Ulrich Wiesner, Snehal Patel

Open access · greenAbstract readReview
In one paragraph

Review in Wiley interdisciplinary reviews. Nanomedicine and nanobiotechnology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
2.6field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 66 citations in OpenAlex.

  1. Article
  2. Review
  3. New trends in diagnosing and treating ovarian cancer using nanotechnology.Frontiers in bioengineering and biotechnology · 2023
    Review
  4. Medical Imaging Technology and Imaging Agents.Advances in experimental medicine and biology · 2023
    Article
  5. Review
  6. Review
  7. Review
  8. Review
  9. Article
  10. Review
  11. Article
  12. Article
  13. Nanotechnology in Radiation Oncology.Hematology/oncology clinics of North America · 2019
    Review
  14. Review
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Michelle S BradburyDepartment of Radiology, Sloan Kettering Institute for Cancer Research, New York, NY, USA.
Mohan PauliahDepartment of Radiology, Sloan Kettering Institute for Cancer Research, New York, NY, USA.
Pat ZanzonicoDepartment of Medical Physics, Sloan Kettering Institute for Cancer Research, New York, NY, USA.
Ulrich WiesnerDepartment of Material Science & Engineering, Cornell University, Ithaca, NY, USA.
Snehal PatelDepartment of Surgery, Sloan Kettering Institute for Cancer Research, New York, NY, USA.
Kettering University · USCornell University · US

Funding

X-RAY CRYSTALLOGRAPHYP30CA008748 · NCI · SLOAN-KETTERING INSTITUTE FOR CANCER RES · PI Nicholas D Socci · 1985 to 2026
$347.4M
Real-time Intraoperative Imaging of Cancer Biomarkers and Peripheral NervesU54CA199081 · NCI · SLOAN-KETTERING INST CAN RESEARCH · PI WIESNER, ULRICH · 2015 to 2019
$8.3M
Renally Excreted Multimodal Core-Shell Silica Nanoparticles as Tumor-Selective RaR01CA161280 · NCI · SLOAN-KETTERING INST CAN RESEARCH · PI BRADBURY, MICHELLE S, WIESNER, ULRICH · 2012 to 2016
$2.7M
NCI NIH HHS P30 CA008748NCI NIH HHS R01 CA161280NCI NIH HHS U54 CA199081
6 · The paper itself

Abstract

The management of regional lymph nodes in patients with melanoma has undergone a significant paradigm shift over the past several decades, transitioning from the use of more aggressive surgical approaches, such as lymph node basin dissection, to the application of minimally invasive sentinel lymph node (SLN) biopsy methods to detect the presence of nodal micrometastases. SLN biopsy has enabled reliable, highly accurate, and low-morbidity staging of regional lymph nodes in early stage melanoma as a means of guiding treatment decisions and improving patient outcomes. The accurate identification and staging of lymph nodes is an important prognostic factor, identifying those patients for whom the expected benefits of nodal resection outweigh attendant surgical risks. However, currently used standard-of-care technologies for SLN detection are associated with significant limitations. This has fueled the development of clinically promising platforms that can serve as intraoperative visualization tools to aid accurate and specific determination of tumor-bearing lymph nodes, map cancer-promoting biological properties at the cellular/molecular levels, and delineate nodes from adjacent critical structures. Among a number of promising cancer-imaging probes that might facilitate achievement of these ends is a first-in-kind ultrasmall tumor-targeting inorganic (silica) nanoparticle, designed to overcome translational challenges. The rationale driving these considerations and the application of this platform as an intraoperative treatment tool for guiding resection of cancerous lymph nodes is discussed and presented within the context of alternative imaging technologies. WIREs Nanomed Nanobiotechnol 2016, 8:535-553. doi: 10.1002/wnan.1380 For further resources related to this article, please visit the WIREs website.

Indexed as

Molecular ImagingNanomedicineNanoparticlesSilicon DioxideHumansLymphatic MetastasisSentinel Lymph NodeSilicon Dioxide

Identifiers

PMID26663853
PMCPMC4902785
OpenAlexW2221690774

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.